ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

IVVD Invivyd Inc

1.32
0.03 (2.33%)
取引時間後
最終更新日: 07:35:48
15分遅延
名称 銘柄コード 市場 種別
Invivyd Inc IVVD NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.03 2.33% 1.32 07:35:48
始値 安値 高値 終値 前日終値
1.33 1.25 1.33 1.32 1.29
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/7/0120:01GLOBEInvivyd Announces its Addition to the Russell 2000® and..
2024/6/1420:07EDGAR2Form 8-K - Current report
2024/6/1420:01GLOBEInvivyd Announces Antiviral Activity of VYD222 (pemivibart)..
2024/6/0705:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0705:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/6/0405:01GLOBEInvivyd to Participate at the Jefferies Global Healthcare..
2024/5/3120:12EDGAR2Form 8-K - Current report
2024/5/3120:05GLOBEInvivyd Announces General Alignment with U.S. FDA on a..
2024/5/3120:00GLOBEInvivyd Announces the Appointment of Timothy Lee as Chief..
2024/5/2920:00GLOBEInvivyd to Present Data at 2024 American Society of Clinical..
2024/5/2407:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2407:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2406:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2405:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2405:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/5/2220:06EDGAR2Form 8-K - Current report
2024/5/2220:00GLOBEInvivyd Elects Two New Independent Members to its Board of..
2024/5/1705:11EDGAR2Form 144 - Report of proposed sale of securities
2024/5/1405:01GLOBEInvivyd to Participate at the H.C. Wainwright 2nd Annual..
2024/5/1005:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/5/1005:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1005:08EDGAR2Form 8-K - Current report
2024/5/1005:01GLOBEInvivyd Reports First Quarter 2024 Financial Results and..
2024/5/0720:38EDGAR2Form 8-K - Current report
2024/5/0720:30GLOBEInvivyd to Pursue Rapid Immunobridging Pathway to Potential..
2024/5/0306:13GLOBEInvivyd to Host Conference Call Discussing First Quarter..
2024/4/3020:30GLOBEInvivyd Announces $20 Million to $25 Million Improvement in..
2024/4/1520:30GLOBEInvivyd Receives Healthcare Common Procedure Coding System..
2024/4/1220:30GLOBEInvivyd Announces CEO Transition
2024/4/0505:01GLOBEInvivyd Provides PEMGARDA™ Launch Update and Announces 2024..
2024/3/2820:00GLOBEInvivyd Reports Full Year 2023 Financial Results and Recent..
2024/3/2304:28GLOBEInvivyd Announces Interim Exploratory Data on VYD222 from..
2024/3/2304:04GLOBEInvivyd Announces FDA Authorization for Emergency Use of..
2024/2/1306:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1006:47EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/2/1006:01EDGAR2Form 8-K - Current report
2024/2/0606:02GLOBEInvivyd to Participate at the Guggenheim Healthcare Talks..
2024/1/2706:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2706:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0821:12EDGAR2Form 8-K - Current report
2024/1/0321:06EDGAR2Form 8-K - Current report
2024/1/0321:00GLOBEInvivyd Submits Request for Emergency Use Authorization..
2023/12/2306:53EDGAR2Form 8-K - Current report
2023/12/2306:51EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/2106:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2106:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2106:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2106:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2106:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2106:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock